Skip to main content
Premium Trial:

Request an Annual Quote

Caliper Life Sciences, US Environmental Protection Agency

Premium
Caliper Gets $1.1M Order Under EPA ToxCast Contract
 
Caliper Life Sciences said this week that it has received a $1.1 million task order from the US Environmental Protection Agency’s ToxCast screening program.
 
The task order falls under a contract signed between Caliper and the EPA in April 2007, under which Caliper could potentially receive $69 million of screening services through the five-year period of the contract [see CBA News 04-13-07]. Including the $1.1 million order announced this week, to date Caliper has received $3.6 million in orders from the EPA.
 
Hopkinton, Mass.-based Caliper said that it expects to complete work associated with the order, which includes predicting how chemicals like pesticides will interact with the environment, humans, and animals, during the current quarter. During this phase of the contract, Caliper will further screen 320 compounds that it previously had tested in an initial phase of research using 230 in vitro assays.
 
“With this new funding, we will expand our testing to determine the potency, or concentration response, of these bioactivities using all 230 of the initial assays,” said David Manyak, Caliper’s executive vice president of discovery services, in a statement.
 
Earlier this month, the firm reported a decline in second-quarter revenues due to a $3.5 million drop year over year in licensing and contract revenues and contract delays for its Caliper Discovery Alliances and Services business [see CBA News 08-08-08]. Company officials said the problems were associated with two contracts, one with the EPA and one with drug giant Pfizer.
 
However, Caliper President and CEO Kevin Hrusovsky said during a conference call following the Q2 results that the contract with the EPA “overall is going very well and is expected to deliver strong growth in the second half and future years.”

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.